Search Results - "Warren, Noelle"

Design and Synthesis of Novel and Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders by Gomez, Laurent, Massari, Mark Eben, Vickers, Troy, Freestone, Graeme, Vernier, William, Ly, Kiev, Xu, Rui, McCarrick, Margaret, Marrone, Tami, Metz, Markus, Yan, Yingzhou G, Yoder, Zachary W, Lemus, Robert, Broadbent, Nicola J, Barido, Richard, Warren, Noelle, Schmelzer, Kara, Neul, David, Lee, Dong, Andersen, Carsten B, Sebring, Kristen, Aertgeerts, Kathleen, Zhou, Xianbo, Tabatabaei, Ali, Peters, Marco, Breitenbucher, J. Guy

“…A series of potent and selective [1,2,4]­triazolo­[1,5-a]­pyrimidine PDE2a inhibitors is reported. The design and improvement of the binding properties of this…”
Get full text

A Critical Evaluation of a Nicotine Vaccine within a Self-Administration Behavioral Model by Moreno, Amira Y, Azar, Marc R, Warren, Noelle A, Dickerson, Tobin J, Koob, George F, Janda, Kim D

“…(S)-Nicotine is a psychostimulant legal drug responsible for causing addiction to tobacco smoking. Tobacco smoking has been irrevocably linked to a number of…”
Get full text

Target Engagement of a Phosphodiesterase 2A Inhibitor Affecting Long-Term Memory in the Rat by Gu, Guibao, Scott, Trevor, Yan, Yingzhuo, Warren, Noelle, Zhang, Adia, Tabatabaei, Ali, Xu, Hao, Aertgeerts, Kathleen, Gomez, Laurent, Morse, Andrew, Li, Yu-Wen, Breitenbucher, J Guy, Massari, Eben, Vivian, Jeffrey, Danks, Anne

“…Inhibition of phosphodiesterase 2A (PDE2A) has been proposed as a potential approach to enhance cognitive functioning and memory through boosting intracellular…”
Get more information

The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety by BUSSE, Chris S, BRODKIN, Jesse, TATTERSALL, David, ANDERSON, Jeffery J, WARREN, Noelle, TEHRANI, Lida, BRISTOW, Linda J, VARNEY, Mark A, COSFORD, Nicholas D. P

“…Previous reports have demonstrated the anxiolytic effect of the potent and systemically active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist…”
Get full text